Study Notes on Alzheimer's Disease and Related Neurocognitive Disorders

Overview of Alzheimer's Disease and Related Economic Burden

  • 2025 report highlights the economic burden of Alzheimer's disease and its impact on society.
  • Alzheimer's disease is described as a public health crisis due to increasing prevalence and risks associated with aging.

Population Aging and Cognitive Disorders

  • Population Aging

    • Significant increase in the population aged 75 and older correlates with higher risks of neurocognitive disorders (NCDs).
    • Awareness needed regarding aging and cognitive function.
  • Myths vs. Reality

    • Common stereotype: Aging leads to cognitive decline (dementia).
    • Research Findings:
    • About 95% of individuals aged 71-79 are free from dementia.
    • Approximately 85% of those aged 80-89 do not have dementia.
    • Crisis Context: Although rising cases of dementia present a public health concern, cognitive decline is not inevitable.

Delirium

  • Definition: An acute, fluctuating disturbance in attention and awareness that develops within hours.
  • Linked Factors:
    • Associated with infections (e.g., UTIs in older adults), medication changes, or metabolic imbalances.
  • Symptoms:
    • Fluctuating alertness: An individual may appear alert one moment and confused shortly after.
  • Clinical Approach:
    • Key mantra: "Delirium unless proven otherwise" emphasizes the need to identify delirium before considering dementia.

Neurocognitive Disorders (NCDs)

  • Dementia:
    • Defined as a severe cognitive decline impacting an individual's capability to live independently.
    • DSM-5: Introduced neurocognitive disorders as a broader diagnostic category, recognizing various conditions leading to cognitive impairment.
  • Classification:
    • Major Neurocognitive Disorder (NCD): Significant cognitive decline affecting daily functioning (e.g., managing finances, medications).
    • Mild Neurocognitive Disorder (mild NCD): Modest decline, but individual retains ability to function independently with compensatory strategies.

Mild Cognitive Impairment (MCI)

  • MCI is a transitional state between normal cognitive aging and more severe impairments such as dementia.
  • Key Takeaway: Less than 15% of individuals with MCI progress to dementia; MCI does not predict dementia.
  • Subtypes:
    • Amnestic MCI: Memory impairment is the primary concern.
    • Non-amnestic MCI: Other cognitive domains such as language or executive function are more affected.

Prevalence and Risk Factors for Dementia

  • Prevalence: Approximately 16% of individuals aged 70+ in the U.S. are diagnosed with dementia.
  • Health Disparities:
    • Incidence is higher in Black and Hispanic populations — up to three times greater for Black adults.
    • Systemic factors contribute to varied risk and diagnosis rates.
  • Gender Differences: Women generally exhibit higher rates of dementia than men, potentially due to hormonal factors.

Alzheimer's Disease

  • Most Common Cause of Dementia:
    • Recognized as a significant cause of mortality with no current cure.
  • Neuropathological Hallmarks:
    • Amyloid Plaques: Extracellular deposits of two types of amyloid beta (AB 40 and AB 42). The ratio of these peptides can indicate disease progression.
    • Neurofibrillary Tangles: Intracellular accumulations of tau protein, leading to neuron death and cognitive decline.

Disease Progression

  • Progressive and insidious decline in cognitive abilities, often starting with memory impairment due to hippocampal changes.
  • Cognitive deficits can include…
    • Language impairments (difficulty finding words).
    • Executive function impairment (planning, decision-making).

Genetic Factors and Alzheimer's Risk

  • Early-Onset Familial Alzheimer's Disease: Rare, typically attributed to specific gene mutations.
  • APOE Dimensions:
    • APOE ε4 allele as a genetic risk factor for late-onset Alzheimer's; however, not deterministic.
  • Lifestyle factors (diet, exercise, emotional well-being) play significant roles alongside genetics.

Current Research and Biomarkers

  • Advancements in Biomarkers:
    • Use of PET scans and blood tests to measure amyloid plaques and tau tangles.
    • Neurofilament light (NFL) as a non-diagnostic marker indicating brain inflammation.
    • Constraints: Unequal access to biomarker research and therapies across demographic groups.

Other Causes of Dementia

  • Lewy Body Disease: Symptoms include fluctuating cognition, visual hallucinations, and movement issues.
  • Vascular Dementia: Caused primarily by strokes, characterized by stepwise cognitive decline tied to cerebrovascular events.
  • Frontotemporal Dementia (FTD): Early onset and notable changes in personality, language, and social conduct; presents in the 50s compared to Alzheimer's, commonly seen in older adults.

Implications for Practice and Research

  • Importance of understanding socio-economic contexts and health disparities when conducting research or clinical evaluations.
  • Recommendations for culturally informed care and awareness of neurocognitive health and its determinants throughout the lifespan.

Conclusion

  • Recognizing that dementia is not an inescapable outcome of aging and that most older adults can maintain cognitive health.
  • Early diagnosis is crucial for appropriate planning and access to resources.